2. Antibody-drug Conjugate/ADC Related
  3. Radionuclide-Drug Conjugates (RDCs)
  4. DOTA-cTMTP1

DOTA-cTMTP1 is a cyclic tumor-homing peptide precursor molecule. DOTA-cTMTP1 selectively binds to XPNPEP2 on highly metastatic tumor cells, accumulates and retains in hepatocellular carcinoma tumors, and maintains a high tumor-to-liver contrast over time in small animal models. After radiolabeling with 68Ga, DOTA-cTMTP1 forms a PET probe for positron emission tomography (PET) imaging of hepatocellular carcinoma (HCC).

For research use only. We do not sell to patients.

Custom Peptide Synthesis

DOTA-cTMTP1

DOTA-cTMTP1 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

DOTA-cTMTP1 Related Antibodies

Top Publications Citing Use of Products

View All Radionuclide-Drug Conjugates (RDCs) Isoform Specific Products:

View All Isoforms
RDC Peptide RDC Antibody RDC Bifunctional Chelator RDC Linker Other

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

DOTA-cTMTP1 is a cyclic tumor-homing peptide precursor molecule. DOTA-cTMTP1 selectively binds to XPNPEP2 on highly metastatic tumor cells, accumulates and retains in hepatocellular carcinoma tumors, and maintains a high tumor-to-liver contrast over time in small animal models. After radiolabeling with 68Ga, DOTA-cTMTP1 forms a PET probe for positron emission tomography (PET) imaging of hepatocellular carcinoma (HCC).[1]

In Vitro

DOTA-cTMTP1 (20 μg; 10 min) exhibits > 99% radiolabeling efficiency when incubated with [68Ga]GaCl3 at 95 °C for 10 min, producing [68Ga]Ga-DOTA-cTMTP1 with a specific activity of 5.19 MBq/nmol[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

DOTA-cTMTP1 Related Antibodies
In Vivo

[68Ga]Ga-DOTA-cTMTP1 (5.2 MBq; i.v.; single dose) exhibits specific, sustained tumor uptake in subcutaneous HCC xenografts, with consistently high tumor-to-liver ratios across all measured time points postinjection[1].
[68Ga]Ga-DOTA-cTMTP1 (i.v.; single dose) enables clear visualization of small HCC lesions in a transgenic mouse model, with increasing tumor-to-liver ratios over 120 min postinjection[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: BALB/c nude (male, 5-6 weeks old, ~20 g)[1]
Dosage: 5.2 MBq
Administration: i.v.; single dose
Result: Reached tumor uptake of 1.3 %ID/g at 15 min, 1.09 %ID/g at 30 min, and 0.74 %ID/g at 150 min postinjection.
Showed tumor uptake of 0.98 %ID/g at 30 min with retention at later time points.
Achieved tumor-to-liver ratios of 2.65 at 30 min, 2.37 at 60 min, 2.14 at 120 min, and 2.69 at 150 min.
Reached tumor-to-muscle ratio of 11.17 at 150 min.
Reduced tumor uptake to 0.36 %ID/g at 30 min and 0.32 %ID/g at 60 min after coinjection of unlabeled TMTP1.
Decreased blood radioactivity from 1.11 %ID/g at 30 min to 0.48 %ID/g at 60 min, and then to 0.22 %ID/g at 120 min.
Molecular Weight

1433.57

Formula

C55H92N20O21S2
Sequence

DOTA-Gly-Gly-Gly-Cys-Gly-Asn-Val-Val-Arg-Gln-Gly-Cys (Disulfide bridge: Cys1-Cys9)
Sequence Shortening

DOTA-GGG-CGNVVRQGC (Disulfide bridge: Cys1-Cys9)
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

DOTA-cTMTP1 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

DOTA-cTMTP1Radionuclide-Drug Conjugates (RDCs)small animal modelsXPNPEP2hepatocellular carcinoma tumorssubcutaneous HCC xenograftsfetal bovine serumhighly metastatic tumor cellstransgenic mouse modelphosphate buffered salineInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
DOTA-cTMTP1
Cat. No.:
HY-P11816
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.